PCAT1 and prostate carcinoma: In the LNCaP prostate cancer cell line, PCAT1 knockdown led to an increased BRCA2 protein expression, while PCAT1 overexpression decreased BRCA2 protein level and impaired repair of double-strand brakes, thus sensitizing cells to PARP1 inhibitors and radiation [122].